The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Review: Systemic inflammation andAlzheimer's disease
Abstract
There is a great deal of evidence suggesting an important role for systemic inflammation in the pathogenesis of A lzheimer's disease. The role of systemic inflammation, and indeed inflammation in general, is still largely considered to be as a contributor to the disease process rather than of aetiological importance although there is emerging evidence to suggest that its role may predate the deposition of amyloid. Therapies aimed at reducing inflammation in individuals with mild cognitive impairment and A lzheimer's disease have been disappointing and have largely focused on the need to ameliorate central inflammation with little attention to the importance of dampening down systemic inflammation. Novel approaches in this area require a greater understanding of the effects of systemic inflammation on the development and progression of A lzheimer's disease and of the communicating pathways between the systemic and central innate immune systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the genetic susceptibility, numerous findings support the involvement in AD pathogenesis of other mechanisms such as inflammation [95], imbalance among production and removal of ROS [96], mitochondrial dysfunction [82], in addition to the β-amyloid cascade [97] and the deficiency of central cholinergic neurotransmitters [98] on which are based most of anti-AD drugs so far approved.”
From Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies (2023) · cites this paper as [95]
In the citing paper
“Crosstalk between systemic and central innate immune systems by the release of inflammatory mediators is observed in AD (Holmes, 2013).”
From The impact of microglial activation on blood-brain barrier in brain diseases (2014) · cites this paper as Holmes, 2013
Citations
Cites
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Self-citationCyclooxygenase in biology and disease
Dubois, R. N., Abramson, S. B., Crofford, L., Gupta, R., Simon, L. S., Putte, L., & Lipsky, P. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,606
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1594 · Cited by 2,490
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Biological basis of the behavior of sick animals
Hart, B. L. (1988) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(88)80004-6 · Cited by 2,223
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Franceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., Panourgia, M. P., Invidia, L., Celani, L., Scurti, M., et al. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.016 · Cited by 2,087
Local self-renewal can sustain CNS microglia maintenance and function throughout adult life
Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W., & Rossi, F. M. V. (2007) · Nature Neuroscience · doi:10.1038/nn2014 · Cited by 1,643
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Self-citationImmunoregulatory Feedback Between Interleukin-1 and Glucocorticoid Hormones
Besedovsky, H., del Rey, A., Sorkin, E., & Dinarello, C. A. (1986) · Science · doi:10.1126/science.3014662 · Cited by 1,519
Holmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R. W., Bullock, R., Love, S., Neal, J. W., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61075-2 · Cited by 1,416
Self-citationCytokine-Associated Emotional and Cognitive Disturbances in Humans
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.445 · Cited by 1,365
Rovelet‐Lecrux, A., Hannequin, D., Raux, G., Meur, N. L., Laquerrière, A., Vital, A., Dumanchin‐Njock, C., Feuillette, S., Brice, A., Vercelletto, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1718 · Cited by 1,284
Systemic inflammation and disease progression in Alzheimer disease
Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139
Self-citationReversing established sepsis with antagonists of endogenous high-mobility group box 1
Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., DiRaimo, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434651100 · Cited by 1,126
A Meta-Analysis of Cytokines in Alzheimer's Disease
Swardfager, W., Lanctôt, K., Rothenburg, L., Wong, A., Cappell, J., & Herrmann, N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.012 · Cited by 1,108
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions
Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.-K., Mack, M., Heikenwalder, M., Brück, W., Priller, J., & Prinz, M. (2007) · Nature Neuroscience · doi:10.1038/nn2015 · Cited by 1,089
Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069
The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
Soscia, S. J., Kirby, J. E., Washicosky, K. J., Tucker, S. M., Ingelsson, M., Hyman, B., Burton, M. A., Goldstein, L. E., Duong, S., Tanzi, R. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009505 · Cited by 1,060
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048
Cytokine-induced sickness behaviour: mechanisms and implications
Konsman, J. P., Parnet, P., & Dantzer, R. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02088-9 · Cited by 999
Clinical trial of indomethacin in Alzheimer's disease
Rogers, J., Kirby, L., Hempelman, S. R., Berry, D. A., McGeer, P. L., Kaszniak, A. W., Zalinski, J., Cofield, M., Mansukhani, L., Willson, P., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1609 · Cited by 991
Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain
Colton, C. A. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9164-4 · Cited by 916
Age, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900
Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis
Farrall, A. J., & Wardlaw, J. M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.015 · Cited by 882
Cytokine-induced sickness behavior: where do we stand?
Dantzer, R. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0613 · Cited by 862
Regulation of innate immune responses in the brain
Rivest, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2565 · Cited by 843
Capuron, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00407-9 · Cited by 797
Campion, D., Dumanchin, C., Hannequin, D., Dubois, B., Belliard, S., Puel, M., Thomas-Anterion, C., Michon, A., Martin, C., Charbonnier, F., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302553 · Cited by 785
Lee, J. W., Lee, Y. K., Yuk, D. Y., Choi, D. Y., Ban, S. B., Oh, K. W., & Hong, J. T. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-37 · Cited by 772
Cunningham, C., Wilcockson, D. C., Campion, S., Lunnon, K., & Perry, V. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2614-05.2005 · Cited by 768
Rates and risk factors for dementia and Alzheimer’s disease: Results from EURODEM pooled analyses
Launer, L. J., Andersen, K., Dewey, M. E., Letenneur, L., Ott, A., Amaducci, L. A., Brayne, C., Copeland, J. R. M., Dartigues, J.-F., Kragh-Sorensen, P., et al. (1999) · Neurology · doi:10.1212/wnl.52.1.78 · Cited by 758
Harrison, N. A., Brydon, L., Walker, C., Gray, M. A., Steptoe, A., & Critchley, H. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.03.015 · Cited by 756
TLR3: Interferon induction by double-stranded RNA including poly(I:C)☆
MATSUMOTO, M., & Seya, T. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.005 · Cited by 704
Kitazawa, M., Oddo, S., Yamasaki, T. R., Green, K. N., & LaFerla, F. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2868-05.2005 · Cited by 697
Immune activation in brain aging and neurodegeneration: too much or too little?
Lucin, K. M., & Wyss-Coray, T. (2009) · Neuron · doi:10.1016/j.neuron.2009.08.039 · Cited by 679
D'Mello, C., Le, T., & Swain, M. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3567-08.2009 · Cited by 675
Blood brain barrier: ageing and microvascular disease-systematic review and meta-analysis
Farrall, A., & Wardlaw, J. M. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.089 · Cited by 640
Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E
Barger, S. W., & Harmon, A. D. (1997) · Nature · doi:10.1038/42257 · Cited by 622
Jones, L., Holmans, P. A., Hamshere, M. L., Harold, D., Moskvina, V., Ivanov, D., Pocklington, A., Abraham, R., Hollingworth, P., Sims, R., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013950 · Cited by 606
Self-citationJacobs, B. L., & Langland, J. (1996) · Virology · doi:10.1006/viro.1996.0259 · Cited by 588
Cunningham, C., Campion, S., Lunnon, K., Murray, C. L., Woods, J. F. C., Deacon, R. M. J., Rawlins, J. N. P., & Perry, V. H. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.07.024 · Cited by 584
Predictors of cognitive decline and mortality of aged people over a 10‐year period
Tilvis, R. S., Kahonen-Vare, M. H., Jolkkonen, J., Valvanne, J., Pitkala, K. H., & Strandberg, T. E. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.3.m268 · Cited by 578
Casserly, I., & Topol, E. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15900-x · Cited by 560
Elevated circulating tumor necrosis factor levels in Alzheimer's disease
Fillit, H. M., Ding, W., Buée, L., Kalman, J., Altstiel, L. D., LAWLOR, B. A., & Wolf-Klein, G. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90490-k · Cited by 513
Edison, P., Archer, H. A., Gerhard, A., Hinz, R., Pavese, N., Turkheimer, F. E., Hammers, A., Tai, Y. F., Fox, N., Kennedy, A., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.001 · Cited by 513
Delirium accelerates cognitive decline in Alzheimer disease
Fong, T. G., Jones, R. N., Shi, P., Marcantonio, E. R., Yap, L., Rudolph, J. L., Yang, F. M., Kiely, D. K., & Inouye, S. K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a4129a · Cited by 501
Alzheimer's disease: The amyloid cascade hypothesis: An update and reappraisal
Hardy, J. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s317 · Cited by 475
A randomized controlled trial of prednisone in Alzheimer’s disease
Aisen, P. S., Davis, K. L., Berg, J. D., Schafer, K., Campbell, K., Thomas, R. G., Weiner, M. F., Farlow, M. R., Sano, M., Grundman, M., et al. (2000) · Neurology · doi:10.1212/wnl.54.3.588 · Cited by 464
A High Plasma Concentration of TNF- Is Associated With Dementia in Centenarians
Brüünsgaard, H., Andersen‐Ranberg, K., Jeune, B., Pedersen, B. K., Skinhøj, P., & Pedersen, B. K. (1999) · The Journals of Gerontology Series A · doi:10.1093/gerona/54.7.m357 · Cited by 458
Ek, M., Kurosawa, M., Lundeberg, T., & Ericsson, A. B. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-22-09471.1998 · Cited by 452
Martich, G. D., Danner, R. L., Ceska, M., & Suffredini, A. F. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.4.1021 · Cited by 444
Pace, J. L., Russell, S. W., Torres, B. A., Johnson, H. M., & Gray, P. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.5.2011 · Cited by 441
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe
Feldman, H. H., Doody, R. S., Kivipelto, M., Sparks, D. L., Waters, D. D., Jones, R. W., Schwam, E., Schindler, R., Hey-Hadavi, J., DeMicco, D. A., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d6476a · Cited by 438
Conti, B. (2004) · Frontiers in bioscience · doi:10.2741/1341 · Cited by 417
Simons, M., Schwärzler, F., Lütjohann, D., von Bergmann, K., Beyreuther, K. T., DICHGANS, J., Wormstall, H., Hartmann, T., & Schulz, J. B. (2002) · Annals of Neurology · doi:10.1002/ana.10292 · Cited by 413
Kuo, H., Yen, C., Chang, C., Kuo, C.-K., Chen, J.-H., & Sorond, F. A. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70099-5 · Cited by 409
Dantzer, R., Konsman, J.-P., Bluthé, R.-M., & Kelley, K. W. (2000) · Autonomic Neuroscience · doi:10.1016/s1566-0702(00)00220-4 · Cited by 400
Licastro, F., Pedrini, S., Caputo, L., Annoni, G., Davis, L. J., Ferri, C., Casadei, V. M., & Grimaldi, L. M. E. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00226-x · Cited by 400
Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice
Krstic, D., Madhusudan, A., Doehner, J., Vogel, P., Notter, T., Imhof, C., Manalastas, A., Hilfiker, M., Pfister, S., Schwerdel, C., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-151 · Cited by 400
Sheng, J. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00069-x · Cited by 388
A randomized controlled trial of prednisone in Alzheimer’s disease
Koch, H. J., & Szecsey, A. (2000) · Neurology · doi:10.1212/wnl.55.7.1067 · Cited by 381
Brydon, L., Harrison, N. A., Walker, C., Steptoe, A., & Critchley, H. D. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.12.007 · Cited by 381
Tooth loss, dementia and neuropathology in the Nun Study
Stein, P. S., Desrosiers, M. F., DONEGAN, S. J., Yepes, J. F., & Kryscio, R. J. (2007) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2007.0046 · Cited by 380
Evidence for a Potent Antiinflammatory Effect of Rosiglitazone
Mohanty, P., Aljada, A., Ghanim, H., Hofmeyer, D., Tripathy, D., Syed, T., Al-Haddad, W., Dhindsa, S., & Dandona, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032103 · Cited by 378
Yamagata, K., Matsumura, K., Inoue, W., Shiraki, T., Suzuki, K., Yasuda, S., Sugiura, H., Cao, C., Watanabe, Y., & Kobayashi, S. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02669.2001 · Cited by 372
Neuroprotective role of the innate immune system by microglia
Glezer, I., Simard, A. R., & Rivest, S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.055 · Cited by 371
Microglial activation and amyloid deposition in mild cognitive impairment: A PET study
Okello, A., Edison, P., Archer, H. A., Turkheimer, F. E., Kennedy, J., Bullock, R., Walker, Z., Kennedy, A., Fox, N., Rossor, M., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338622.27876.0d · Cited by 367
Gold, M., Alderton, C., Zvartau-Hind, M., Egginton, S., Saunders, A. M., Irizarry, M., Craft, S., Landreth, G., Linnamägi, Ü., & Sawchak, S. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000318845 · Cited by 361
Goehler, L. E., Gaykema, R. P. A., Nguyen, K. T., Lee, J. E., Tilders, F. J. H., Maier, S. F., & Watkins, L. R. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02799.1999 · Cited by 357
The Neuropathology of Septic Shock
Sharshar, T., Annane, D., de la Gradmaison, G. L., Brouland, J. P., Hopkinson, N. S., & Gray, F. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00494.x · Cited by 348
Pathway across the blood–brain barrier
Ek, M., Engblom, D., Saha, S., Blomqvist, A. G., Jakobsson, P., & Ericsson‐Dahlstrand, A. (2001) · Nature · doi:10.1038/35068632 · Cited by 347
Neural Origins of Human Sickness in Interoceptive Responses to Inflammation
Harrison, N. A., Brydon, L., Walker, C., Gray, M. A., Steptoe, A., Dolan, R. J., & Critchley, H. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.03.007 · Cited by 345
A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphism
Kamboh, M. I., Sanghera, D. K., Ferrell, R. E., & DeKosky, S. T. (1995) · Nature Genetics · doi:10.1038/ng0895-486 · Cited by 336
Extended results of the Alzheimer's disease anti‐inflammatory prevention trial
Breitner, J. C. S., Baker, L. D., Montine, T. J., Meinert, C. L., Lyketsos, C. G., Ashe, K. H., Brandt, J., Craft, S., Evans, D. A., Green, R. C., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.12.014 · Cited by 327
Goehler, L. E., Relton, J. K., Dripps, D. J., Kiechle, R., Tartaglia, N. R., Maier, S. F., & Watkins, L. R. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00020-8 · Cited by 326
Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1.
Kent, S., Bluthé, R.-M., Dantzer, R., Hardwick, A. J., KELLEY, K. W., Rothwell, N. J., & Vannice, J. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9117 · Cited by 325
Atorvastatin for the Treatment of Mild to Moderate Alzheimer Disease: Preliminary Results
Sparks, D. L., Sabbagh, M. N., Connor, D. J., Lopez, J., Launer, L. J., Browne, P., Wasser, D., Johnson-Traver, S., Lochhead, J., & Ziolwolski, C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.5.753 · Cited by 319
Anorexia of infection as a mechanism of host defense
Murray, M., & Murray, A. (1979) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/32.3.593 · Cited by 313
Jaturapatporn, D., Isaac, M. G. E. K. N., McCleery, J. M., & Tabet, N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006378.pub2 · Cited by 311
Sparkman, N. L., Buchanan, J. B., Heyen, J. R. R., Chen, J., Beverly, J. L., & Johnson, R. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3376-06.2006 · Cited by 307
Dunn, A. J. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11171-3 · Cited by 302
The role of TNF and its receptors in Alzheimer's disease
Perry, R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00291-3 · Cited by 301
Lue, L. F., Brachova, L., CIVIN, W. H., & Rogers, J. (1996) · PubMed · Cited by 299
Dunn, A. J. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90522-x · Cited by 298
Biessels, G. J., & Kappelle, L. J. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331041 · Cited by 293
Contribution of systemic inflammation to chronic neurodegeneration
Perry, V. H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0722-x · Cited by 286
Bluthé, R.-M., Layé, S., Michaud, B., Combe, C., Dantzer, R., & Parnet, P. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.01348.x · Cited by 283
Krüger, R., Vieira-Saecker, A. M. M., Kuhn, W., Berg, D., M�ller, T., K�hnl, N., Fuchs, G., Storch, A., Hungs, M., Woitalla, D., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5 · Cited by 281
Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus
Bonaccorso, S., Marino, V., Biondi, M., Grimaldi, F., Ippoliti, F., & Maes, M. H. J. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00264-1 · Cited by 280
Shock and Multiple-Organ Dysfunction after Self-Administration of Salmonella Endotoxin
da Silva, A. M. T., Kaulbach, H. C., Chuidian, F. S., Lambert, D. R., Suffredini, A. F., & Danner, R. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282005 · Cited by 276
Kamer, A. R., Craig, R. G., Pirraglia, E., Dasanayake, A. P., Norman, R. G., Boylan, R. J., Nehorayoff, A., Glodzik, L., Bryś, M., & de Leon, M. J. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.08.013 · Cited by 271
Resilience to Bacterial Infection: Difference between Species Could Be Due to Proteins in Serum
Warren, H. S., Fitting, C., Hoff, E., Adib‐Conquy, M., Beasley‐Topliffe, L., Tesini, B., Liang, X., Valentine, C., Hellman, J., Hayden, D., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/649557 · Cited by 269
Fever and Reduced Iron: Their Interaction as a Host Defense Response to Bacterial Infection
Kluger, M. J., & Rothenburg, B. A. (1979) · Science · doi:10.1126/science.760197 · Cited by 265
Cao, C., Matsumura, K., Yamagata, K., & Watanabe, Y. (1995) · Brain Research · doi:10.1016/0006-8993(95)00839-i · Cited by 252
Quan, N., Stern, E. L., Whiteside, M. B., & Herkenham, M. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00193-3 · Cited by 251
Proinflammatory cytokines, sickness behavior, and Alzheimer disease
Holmes, C., Cunningham, C. M., Zotova, E., Culliford, D. J., & Perry, V. H. (2011) · Neurology · doi:10.1212/wnl.0b013e318225ae07 · Cited by 250
Self-citationLue, L.-F., Brachova, L., Civin, H. W., & Rogers, J. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199655100-00008 · Cited by 246
Blood-brain barrier alterations in ageing and dementia
Popescu, B. O., Toescu, E. C., Popescu, L. M., Bajenaru, O. A., Muresanu, D. F., Schultzberg, M., & Bogdanović, N. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.321 · Cited by 242
Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice.
Bluthé, R., Michaud, B., Poli, V., & Dantzer, R. (2000) · Physiology and Behavior · doi:10.1016/s0031-9384(00)00269-9 · Cited by 239
Plasma cytokines profile in older subjects with late onset Alzheimer’s disease or vascular dementia
Zuliani, G., Ranzini, M., Guerra, G., Rossi, L., Munari, M. R., Zurlo, A., Volpato, S., Atti, A. R., Blè, A., & Fellin, R. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.02.008 · Cited by 236
Circulating interleukin‐6 mediates the febrile response to localised inflammation in rats
Cartmell, T., Poole, S., Turnbull, A. V., Rothwell, N. J., & Luheshi, G. N. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00653.x · Cited by 233
Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease
Combrinck, M. I., Perry, V. H., & Cunningham, C. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00030-1 · Cited by 231
Microglia activation in sepsis: a case-control study.
Lemstra, A. W., Woud, J. C. G. I., Hoozemans, J. J. M., van Haastert, E. S., Rozemüller, A. J. M., Eikelenboom, P., & van Gool, W. A. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-4 · Cited by 229
Breder, C. D., Hazuka, C., Ghayur, T., Klug, C., Huginin, M., Yasuda, K., Teng, M., & Saper, C. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11393 · Cited by 226
Age and neuroinflammation: a lifetime of psychoneuroimmune consequences
Godbout, J. P., & Johnson, R. W. (2009) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2009.02.007 · Cited by 224
Wong, M., Bongiorno, P. B., Rettori, V., McCann, S. M., & Licinio, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.227 · Cited by 223
Lacroix, S., Feinstein, D., & Rivest, S. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00189.x · Cited by 223
Relationship between Helicobacter pylori infection and Alzheimer disease
Kountouras, J., Tsolaki, M., Gavalas, E., Boziki, M. K., Zavos, C., Karatzoglou, P., Chatzopoulos, D., & Venizelos, I. (2006) · Neurology · doi:10.1212/01.wnl.0000203644.68059.5f · Cited by 221
Nadeau, S., & Rivest, S. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03456.2000 · Cited by 217
Field, R. H., Campion, S., Warren, C., Murray, C., & Cunningham, C. M. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.04.004 · Cited by 215
Suppression of fever after lesions of the anteroventral third ventricle in guinea pigs
Blatteis, C. M., Bealer, S. L., Hunter, W. S., Llanos, J.-Q., Ahokas, R. A., & Mashburn, T. A. (1983) · Brain Research Bulletin · doi:10.1016/0361-9230(83)90124-7 · Cited by 213
Association between Dementia and Infectious Disease
Dunn, N. R., Mullee, M., Perry, V. H., & Holmes, C. (2005) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000165511.52746.1f · Cited by 202
Self-citationBreder, C. D., & Saper, C. B. (1996) · Brain Research · doi:10.1016/0006-8993(95)01474-8 · Cited by 198
Bone, R. C. (1991) · CHEST Journal · doi:10.1378/chest.100.3.802 · Cited by 194
Statins for the prevention of dementia
McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160.pub2 · Cited by 193
McCusker, S. M., Curran, M. D., Dynan, K., McCullagh, C. D., Urquhart, D., Middleton, D., Patterson, C. C., McIlroy, S. P., & Passmore, A. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04008-3 · Cited by 191
Glucocorticoids Play a Fundamental Role in Protecting the Brain during Innate Immune Response
Nadeau, S., & Rivest, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05536.2003 · Cited by 190
Low-dose endotoxemia and human neuropsychological functions
Krabbe, K. S., Reichenberg, A., Yirmiya, R., Smed, A., Pedersen, B. K., & Bruunsgaard, H. (2005) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.04.010 · Cited by 189
Blood-Based Biomarkers of Alzheimer's Disease: Challenging but Feasible
Thambisetty, M., & Lovestone, S. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.84 · Cited by 182
Sly, L. M., KRZESICKI, R. F., Brashler, J. R., Buhl, A.-L., McKinley, D. D., Carter, D. B., & Chin, J. E. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00730-4 · Cited by 180
Bermejo, P., Martín-Aragón, S., Benedí, J., Susín, C., Felici, E., Gil, P., Ribera, J. M., & Villar, Á. M. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.02.002 · Cited by 178
Kahn, M. S., Kranjac, D., Alonzo, C. A., Haase, J. H., Cedillos, R. O., McLinden, K. A., Boehm, G. W., & Chumley, M. J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.01.010 · Cited by 177
Yokokura, M., Mori, N., Yagi, S., Yoshikawa, E., Kikuchi, M., Yoshihara, Y., Wakuda, T., Sugihara, G., Takebayashi, K., Suda, S., et al. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1612-0 · Cited by 174
Lestage, J., Verrier, D., Palin, K., & Dantzer, R. (2002) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00014-4 · Cited by 170
Prostaglandins as inflammatory messengers across the blood-brain barrier
Engblom, D., Ek, M., Saha, S., Ericsson‐Dahlstrand, A., Jakobsson, P., & Blomqvist, A. G. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-001-0289-z · Cited by 167
Circulating cytokines in Alzheimer's disease
Singh, V. K., & Guthikonda, P. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00023-x · Cited by 163
Understanding immunity requires more than immunology
Tracey, K. J. (2010) · Nature Immunology · doi:10.1038/ni0710-561 · Cited by 160
Wiley, C. A., Lopresti, B. J., Venneti, S., Price, J. C., Klunk, W. E., DeKosky, S. T., & Mathis, C. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.511 · Cited by 160
de Jong, D., Jansen, R. W. M. M., Hoefnagels, W. H. L., Mj, J.-E., Verbeek, M. M., Borm, G. F., & Kremer, B. P. H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001475 · Cited by 150
Rezaie, P., & Male, D. K. (2002) · Journal of the History of the Neurosciences · doi:10.1076/jhin.11.4.325.8531 · Cited by 145
Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence
Appleyard, C. B., McCafferty, D., Tigley, A. W., Swain, M. G., & Wallace, J. L. (1996) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1996.270.1.g42 · Cited by 144
Inflammation in depression: is adiposity a cause?
Shelton, R. C., & Miller, A. H. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/rshelton · Cited by 143
Marksteiner, J., Kemmler, G., Weiss, E. M., Knaus, G., Ullrich, C., Mechtcheriakov, S., OBERBAUER, H., Auffinger, S., Hinterhoelzl, J., Hinterhuber, H., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.03.011 · Cited by 143
Sub-pyrogenic systemic inflammation impacts on brain and behavior, independent of cytokines
Teeling, J. L., Felton, L. M., Deacon, R. M. J., Cunningham, C. M., Rawlins, J. N. P., & Perry, V. H. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.01.012 · Cited by 140
Blood levels of histamine, IL-1β, and TNF-α in patients with mild to moderate alzheimer disease
Alvarez, X. A., Franco, A., Fernández-Novoa, L., & Cacabelos, R. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815005 · Cited by 139
Teeling, J. L., Cunningham, C., Newman, T. A., & Perry, V. H. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.11.006 · Cited by 139
Bone-marrow-derived microglia: myth or reality?
Soulet, D., & Rivest, S. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.04.002 · Cited by 139
PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET
Venneti, S., Lopresti, B. J., Wang, G., Hamilton, R. L., Mathis, C. A., Klunk, W. E., Apte, U. M., & Wiley, C. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.005 · Cited by 138
Spinas, G. A., Bloesch, D., Keller, U. B., Zimmerli, W., & Cammisuli, S. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/163.1.89 · Cited by 135
Rada, P. V., Mark, G. P., Vitek, M. P., Mangano, R. M., Blume, A. J., Beer, B., & Hoebel, B. G. (1991) · Brain Research · doi:10.1016/0006-8993(91)91330-4 · Cited by 126
Buchhave, P., Zetterberg, H., Blennow, K., Minthon, L., Janciauskiene, S. M., & Hansson, O. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.10.012 · Cited by 120
Neuroinflammation‐induced acceleration of amyloid deposition in the APPV717F transgenic mouse
Qiao, X., Cummins, D. J., & Paul, S. M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01666.x · Cited by 119
Rahkonen, T. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.4.519 · Cited by 116
Peripheral benzodiazepine binding sites in Alzheimer's disease frontal and temporal cortex
Diorio, D. L., Welner, S. A., Butterworth, R. F., Meaney, M. J., & Suranyi-Cadotte, B. E. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90106-t · Cited by 114
Depression and the Risk of Alzheimer Disease
Andersen, K., Lolk, A., rensen, P. K.-S., Petersen, N. E., & Green, A. (2005) · Epidemiology · doi:10.1097/01.ede.0000152116.32580.24 · Cited by 113
Increased Cerebrospinal Fluid Helicobacter Pylori Antibody in Alzheimer’s Disease
Kountouras, J., Boziki, M. K., Gavalas, E., Zavos, C., Deretzi, G., Grigoriadis, N., Tsolaki, M., Chatzopoulos, D., Katsinelos, P., Tzilves, D., et al. (2009) · International Journal of Neuroscience · doi:10.1080/00207450902782083 · Cited by 113
Mechanisms of the Behavioural Effects of Cytokines
Dantzer, R., Aubert, A., Bluthé, R.-M., Gheusi, G., Cremona, S., Layé, S., Konsman, J. P., Parnet, P., & Kelley, K. W. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-0-585-37970-8_6 · Cited by 112
Kamata, M. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00067-x · Cited by 105
Zhang, Y., Lu, J., Elmquist, J. K., & Saper, C. B. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10743 · Cited by 102
Itzhaki, R. F., & Wozniak, M. A. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.003 · Cited by 101
Murray, C., Skelly, D., & Cunningham, C. M. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-50 · Cited by 100
The puzzle of depression and acute coronary syndrome: Reviewing the role of acute inflammation
Poole, L., Dickens, C. M., & Steptoe, A. (2011) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2010.12.009 · Cited by 100
Johnson, W. J., Marino, P. A., Schreiber, R. D., et al. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.2.1038 · Cited by 97
Inflammatory cytokines, behaviour and age as determinants of self-rated health in women
Undén, A., Andréasson, A., Elofsson, S., Brismar, K., Mathsson, L., Rönnelid, J., & Lekander, M. (2007) · Clinical Science · doi:10.1042/cs20060128 · Cited by 94
Nadeau, S., & Rivest, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3370 · Cited by 94
Midlife C-reactive protein and risk of cognitive decline: A 31-year follow-up
Laurin, D., Curb, J. D., Masaki, K., White, L. R., & Launer, L. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.008 · Cited by 93
Cohen, O., Reichenberg, A., Perry, C., Ginzberg, D., Pollmächer, T., Soreq, H., & Yirmiya, R. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:21:3:199 · Cited by 88
Signaling the brain in inflammation: the role of endothelial cells
Matsumura, K. (2004) · Frontiers in bioscience · doi:10.2741/1439 · Cited by 87
Inflammatory markers in Alzheimer's disease and multi-infarct dementia
Luigi, A. D., Fragiacomo, C., Lucca, U., Quadri, P., Tettamanti, M., & Simoni, M. G. D. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00313-x · Cited by 85
The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype
Gérard, H. C., Wildt, K. S., Whittum‐Hudson, J. A., Lai, Z., Ager, J. W., & Hudson, A. P. (2005) · Microbial Pathogenesis · doi:10.1016/j.micpath.2005.05.002 · Cited by 85
Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats
Bluthé, R.-M., Beaudu, C., Kelley, K. W., & Dantzer, R. (1995) · Brain Research · doi:10.1016/0006-8993(95)00194-u · Cited by 83
Bertrand, V., Guimbaud, R., Tulliez, M., Mauprivez, C., Sogni, P., Couturier, D., Giroud, J. P., Chaussade, S., & Chauvelot‐Moachon, L. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701968 · Cited by 82
Interleukin-1 mediates behavioural but not metabolic effects of tumor necrosis factor α in mice
Bluthé, R.-M., Dantzer, R., & Kelley, K. W. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90184-r · Cited by 79
Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease
van Duijn, C. M., Hofman, A., & Nagelkerken, L. M. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90666-w · Cited by 79
Plasma Aβ42 correlates positively with increased body fat in healthy individuals
Balakrishnan, K., Verdile, G., Mehta, P. D., Beilby, J. P., Nolan, D. A., Galvao, D. A., Newton, R. U., Gandy, S., & Martins, R. N. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8305 · Cited by 76
INTERFERON IN HUMAN SERUM AFTER INJECTION OF ENDOTOXIN
Sauter, C., & Wolfensberger, C. (1980) · The Lancet · doi:10.1016/s0140-6736(80)90189-0 · Cited by 75
Association between the TNFα‐308 A/G polymorphism and the onset‐age of Alzheimer disease
Álvarez, V., Mata, I. F., González, P., Lahoz, C., Martínez, C., Peña, J., Guisasola, L. M., & Coto, E. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10515 · Cited by 75
Lazarus, M., Kubata, B. K., Eguchi, N., Fujitani, Y., Urade, Y., & Hayaishi, O. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2614 · Cited by 75
The role of the interleukin-1/Toll-like receptor superfamily in inflammation and host defence
Fitzgerald, K. A., & O'Neill, L. A. J. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00396-8 · Cited by 73
Role of Infection in the Pathogenesis of Alzheimerʼs Disease
Holmes, C., & Cotterell, D. (2009) · CNS Drugs · doi:10.2165/11310910-000000000-00000 · Cited by 71
Self-citationSerum tumor necrosis factor (TNF) in Alzheimer's disease and multi-infarct dementia.
Cacabelos, R., Alvarez, X. A., Franco-Maside, A., Fernández‐Novoa, L., & Caamaño, J. C. (1994) · PubMed · Cited by 69
Interleukin‐1 beta production in the rabbit brain during endotoxin‐induced fever.
Nakamori, T., Morimoto, A., Yamaguchi, K., Watanabe, T., & Murakami, N. (1994) · The Journal of Physiology · doi:10.1113/jphysiol.1994.sp020121 · Cited by 67
Cochrane review on ‘Statins for the treatment of dementia’
McGuinness, B., O’Hare, J., Craig, D., Bullock, R. A., Malouf, R. S., & Passmore, P. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3797 · Cited by 64
Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases
Jiang, Y., Deacon, R., Anthony, D. C., & Campbell, S. J. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.06.017 · Cited by 64
Smagin, G. N., Swiergiel, A. H., & Dunn, A. J. (1996) · Psychoneuroendocrinology · doi:10.1016/0306-4530(95)00019-4 · Cited by 64
APOE polymorphism is associated with risk of severe sepsis in surgical patients*
Moretti, E. W., Morris, R. W., Podgoreanu, M. V., Schwinn, D. A., Newman, M. F., Bennett, E. R., Moulin, V. G., Uzo, U., & Laskowitz, D. T. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000186368.96146.fb · Cited by 62
Multiple neural mechanisms of fever
Székely, M., Balaskó, M., KULCHITSKY, V. A., Simons, C. T., Ivanov, A. I., & Romanovsky, A. A. (2000) · Autonomic Neuroscience · doi:10.1016/s1566-0702(00)00223-x · Cited by 62
Endres, S., Whitaker, R., GHORBANI, R., Meydani, S. N., & Dinarello, C. A. (1996) · Immunology · doi:10.1046/j.1365-2567.1996.472535.x · Cited by 61
The relationship between Helicobacter pylori infection and Alzheimer’s disease in Japan
Shiota, S., Murakami, K., Yoshiiwa, A., Yamamoto, K., Ohno, S., Kuroda, A., Mizukami, K., Hanada, K., Okimoto, T., Kodama, M., et al. (2011) · Journal of Neurology · doi:10.1007/s00415-011-5957-5 · Cited by 61
Afferent Pathways of Pyrogen Signalinga
Blatteis, C. M., SEHIC, E., & Li, S. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08318.x · Cited by 60
Male Sex Hormones and Systemic Inflammation in Alzheimer Disease
Butchart, J., Birch, B. R., Bassily, R., Wolfe, L., & Holmes, C. (2012) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318258cd63 · Cited by 55
Self-citationSignaling the brain in the early sickness syndrome: are sensory nerves involved?
Romanovsky, A. A. (2004) · Frontiers in bioscience · doi:10.2741/1247 · Cited by 52
A Pilot Study of Prednisone in Alzheimer's Disease
Aisen, P. S. S., Marin, D. B., Altstiel, L. D., et al. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106879 · Cited by 49
Decreased behavioral impairments in an Alzheimer mice model by interfering with TNF-alpha metabolism
Giuliani, F., Vernay, A., Leuba, G., & Schenk, F. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.07.009 · Cited by 49
Weiner, J. A., & Chun, J. J. M. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970505)381:2 · Cited by 46
Statins: The Role in the Treatment and Prevention of Alzheimer's Neurodegeneration
Pac-Soo, C., Lloyd, D. G., Vizcaychipi, M. P., & Ma, D. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110524 · Cited by 42
Effects of prostaglandins and cyclic AMP on cytokine production in rat leukocytes
Oh‐ishi, S., Utsunomiya, I., Yamamoto, T., et al. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00005-2 · Cited by 42
Gene Signature in Alzheimer's Disease and Environmental Factors: The Virus Chronicle
Licastro, F., Carbone, I., Ianni, M., & Porcellini, E. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110755 · Cited by 40
Nervous System Lyme Disease: Is There a Controversy?
HALPERIN, J. J. (2011) · Seminars in Neurology · doi:10.1055/s-0031-1287652 · Cited by 33
Chen, Y., Chen, H., Lan, J.-L., & Chen, D. (2010) · Joint Bone Spine · doi:10.1016/j.jbspin.2010.01.017 · Cited by 31
Differential Effects of IL-1β and Ibuprofen after Endotoxic Challenge in Mice
Mansilla‐Roselló, A., Ferrón-Orihuela, J. A., Ruiz‐Cabello, F., et al. (1997) · Journal of Surgical Research · doi:10.1006/jsre.1996.4982 · Cited by 30
Sacco, S., Agnello, D., Sottocorno, M., Lozza, G., Monopoli, A., Villa, P., & Ghezzi, P. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052063.x · Cited by 29
Effect of a nonsteroidal antiinflammatory drug on synovial fluid in osteoarthritis.
Schumacher, H. R., Meng, Z., Sieck, M. S., et al. (1996) · PubMed · Cited by 26
Bluthé, R.-M., Layé, S., Michaud, B., Combe, C., Dantzer, R., & Parnet, P. (2000) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2000.01348.x · Cited by 26
Shirinsky, I. V., Zheltova, O. I., Solovyova, N. Y., Va, K., & Shirinsky, V. S. (2008) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740802363776 · Cited by 23
Flagged first, then by citations
Research works printed but not linked: 1
- Bohac D, 2002, A 24‐week randomized, double‐blind, placebo‐controlled study of the efficacy and tolerability of TNFR: Fc (etanercept) in the treatment of dementia of the Alzheimer type, Neurobiol Aging, 23, 315
Cited by
Sorted by citations
The impact of microglial activation on blood-brain barrier in brain diseases
da Fonseca, A. C. C., Matias, D., Garcia, C., Amaral, R., Geraldo, L. H., Freitas, C., & Lima, F. R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00362 · Cited by 572
Chen, S. G., Stribinskis, V., Rane, M. J., Demuth, D. R., Gozal, E., Roberts, A. M., Jagadapillai, R., Liu, R., Choe, K., Shivakumar, B., et al. (2016) · Scientific Reports · doi:10.1038/srep34477 · Cited by 463
TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease
Yang, J., Wise, L., & Fukuchi, K.-I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00724 · Cited by 387
Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration
Friedland, R. P. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142841 · Cited by 338
The dual roles of cytokines in Alzheimer’s disease: update on interleukins, TNF-α, TGF-β and IFN-γ
Zheng, C., Zhou, X.-W., & Wang, J.-Z. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0054-4 · Cited by 292
Metadata
- Authors
- Holmes, C.
- Affiliations
- Moorgreen Hospital (GB)
- Corresponding author
- Holmes, C.
- ORCID
- Holmes, C.
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2013-01-22
- Volume
- 39
- Issue
- 1
- Pages
- 51-68
- ISSN
- 0305-1846 (ISSN-L)
- 1365-2990
- OpenAlex
- W1916976076
- Semantic Scholar
- 22fc4893fe1c0cf60f5834083c9fe4f5159933fd
- Cited by
- 356
- References
- 208
- Citations by year
- 2026: 17 · 2025: 12 · 2024: 29 · 2023: 52 · 2022: 48 · 2021: 33 · 2020: 38 · 2019: 32 · 2018: 23 · 2017: 24 · 2016: 15 · 2015: 16 · 2014: 11 · 2013: 4
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropathology and Applied Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer Society
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- systemic inflammation, Alzheimer's disease, pathogenesis, amyloid deposition, mild cognitive impairment, anti-inflammatory therapy, innate immune system, neuroinflammation
- MeSH terms
- Alzheimer Disease, Animals, Humans, Inflammation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review